{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T13:31:39Z","timestamp":1783344699297,"version":"3.54.6"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"'Qingmiao' Talent Program of the Inner Mongolia Hospital of Peking University Cancer Hospital","award":["QM202312"],"award-info":[{"award-number":["QM202312"]}]},{"name":"the Joint Science and Technology Research Project of Public Hospitals","award":["2023GLLH0123"],"award-info":[{"award-number":["2023GLLH0123"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s00210-025-04418-y","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T11:16:34Z","timestamp":1754478994000},"page":"1541-1547","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Case report: tigecycline-induced procalcitonin elevation"],"prefix":"10.1007","volume":"399","author":[{"given":"Benben","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongsheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,6]]},"reference":[{"key":"4418_CR1","doi-asserted-by":"publisher","unstructured":"Althomali SA (2022) Tigecycline-induced clinical jaundice: a case report and review of the literature. J Infect Dis Epidemiol 8:267.\u00a0https:\/\/doi.org\/10.23937\/2474-3658\/1510267","DOI":"10.23937\/2474-3658\/1510267"},{"issue":"1","key":"4418_CR2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1080\/14737159.2018.1407244","volume":"18","author":"JJ Choi","year":"2018","unstructured":"Choi JJ, McCarthy MW (2018) Novel applications for serum procalcitonin testing in clinical practice. Expert Rev Mol Diagn 18(1):27\u201334. https:\/\/doi.org\/10.1080\/14737159.2018.1407244","journal-title":"Expert Rev Mol Diagn"},{"issue":"43","key":"4418_CR3","doi-asserted-by":"publisher","first-page":"e22638","DOI":"10.1097\/md.0000000000022638","volume":"99","author":"Q Fan","year":"2020","unstructured":"Fan Q, Huang W, Weng Y, Xie X, Shi Z (2020) Hypofibrinogenemia induced by high-dose tigecycline-case report and review of literature. Medicine 99(43):e22638. https:\/\/doi.org\/10.1097\/md.0000000000022638","journal-title":"Medicine"},{"issue":"6","key":"4418_CR4","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1111\/jcpt.13212","volume":"45","author":"W Fang","year":"2020","unstructured":"Fang W, Yi D, Sun L, Wang C (2020) Analysis of clinical characteristics of tigecycline-induced acute pancreatitis. J Clin Pharm Therapeutics 45(6):1320\u20134. https:\/\/doi.org\/10.1111\/jcpt.13212","journal-title":"J Clin Pharm Therapeutics"},{"key":"4418_CR5","doi-asserted-by":"publisher","unstructured":"Liang J, Zhao K, Zhu L, Liu Y\u00a0(2018) Tigecycline induced cholestatic liver injury: a case report. J Infect Dis Epidemiol 4:60.\u00a0https:\/\/doi.org\/10.23937\/2474-3658\/1510060","DOI":"10.23937\/2474-3658\/1510060"},{"issue":"25","key":"4418_CR6","doi-asserted-by":"publisher","first-page":"e16158","DOI":"10.1097\/md.0000000000016158","volume":"98","author":"J Jun","year":"2019","unstructured":"Jun J, Lee SR, Lee JY, Choi MJ, Noh JY, Cheong HJ et al (2019) Pneumonitis and concomitant bacterial pneumonia in patients receiving pembrolizumab treatment: three case reports and literature review. Medicine 98(25):e16158. https:\/\/doi.org\/10.1097\/md.0000000000016158","journal-title":"Medicine"},{"issue":"5","key":"4418_CR7","doi-asserted-by":"publisher","first-page":"721","DOI":"10.11817\/j.issn.1672-7347.2024.230589","volume":"49","author":"M Liu","year":"2024","unstructured":"Liu M, Tang Y, Xiao Y, Yan L, Xie L, Long X et al (2024) Diagnostic value of procalcitonin in infections in patients with malignant hematologic diseases. Zhong nan da xue xue bao Yi xue ban JCentral South University Med Sci 49(5):721\u20139. https:\/\/doi.org\/10.11817\/j.issn.1672-7347.2024.230589","journal-title":"Zhong nan da xue xue bao Yi xue ban JCentral South University Med Sci"},{"issue":"01","key":"4418_CR8","doi-asserted-by":"publisher","first-page":"e89","DOI":"10.1055\/s-0037-1603895","volume":"7","author":"J Markic","year":"2017","unstructured":"Markic J, Saraga M, Dahlem P (2017) Sepsis biomarkers in neonates and children: c-reactive protein and procalcitonin. J Child Sci 7(01):e89\u2013e95","journal-title":"J Child Sci"},{"issue":"3","key":"4418_CR9","doi-asserted-by":"publisher","first-page":"130","DOI":"10.2146\/ajhp150894","volume":"74","author":"J McMahan","year":"2017","unstructured":"McMahan J, Moenster RP (2017) Tigecycline-induced coagulopathy. Am J Health-Syst Pharm: AJHP: Off J Am Soc Health-Syst Pharmacists 74(3):130\u20134. https:\/\/doi.org\/10.2146\/ajhp150894","journal-title":"Am J Health-Syst Pharm: AJHP: Off J Am Soc Health-Syst Pharmacists"},{"issue":"1","key":"4418_CR10","doi-asserted-by":"publisher","first-page":"115","DOI":"10.2169\/internalmedicine.7192-21","volume":"61","author":"Y Nishimura","year":"2022","unstructured":"Nishimura Y, Kewcharoen J, Narimasu T (2022) Extremely elevated procalcitonin in a case of acetaminophen overdose and acute liver injury. Internal Med (Tokyo, Japan) 61(1):115\u20138. https:\/\/doi.org\/10.2169\/internalmedicine.7192-21","journal-title":"Internal Med (Tokyo, Japan)"},{"key":"4418_CR11","unstructured":"Notice of the National Medical Products Administration on issuing guiding principles for collection and reporting of adverse drug reactions in individual cases [National Medical Products Administration.:[2025\u201302\u201313]. Available from: https: \/\/www.nmpa.gov.cn\/xxgk\/ggtg\/ypggtg\/ ypqtggtg\/20181221\u2013172901438.html."},{"issue":"4","key":"4418_CR12","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1097\/pts.0000000000001213","volume":"20","author":"S Pandit","year":"2024","unstructured":"Pandit S, Soni D, Krishnamurthy B, Belhekar MN (2024) Comparison of WHO-UMC and Naranjo scales for causality assessment of reported adverse drug reactions. J Patient Safety 20(4):236\u20139. https:\/\/doi.org\/10.1097\/pts.0000000000001213","journal-title":"J Patient Safety"},{"issue":"4","key":"4418_CR13","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1128\/aac.43.4.738","volume":"43","author":"PJ Petersen","year":"1999","unstructured":"Petersen PJ, Jacobus NV, Weiss WJ, Sum PE, Testa RT (1999) In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9-t-butylglycylamido derivative of minocycline (GAR-936). Antimicrobial Agents Chemother 43(4):738\u201344. https:\/\/doi.org\/10.1128\/aac.43.4.738","journal-title":"Antimicrobial Agents Chemother"},{"key":"4418_CR14","doi-asserted-by":"publisher","first-page":"761167","DOI":"10.3389\/fphar.2021.761167","volume":"12","author":"X Shi","year":"2021","unstructured":"Shi X, Zuo C, Yu L, Lao D, Li X, Xu Q et al (2021) Real-world data of tigecycline-associated drug-induced liver injury among patients in China: a 3-year retrospective study as assessed by the updated RUCAM. Front Pharmacol 12:761167. https:\/\/doi.org\/10.3389\/fphar.2021.761167","journal-title":"Front Pharmacol"},{"key":"4418_CR15","doi-asserted-by":"publisher","unstructured":"Shi X, Lao D, Xu Q, Li X, Lv Q (2022) A case report of drug-induced liver injury after tigecycline administration: histopathological evidence and a probable causality grading as assessed by the updated RUCAM diagnostic scale. BMC Infectious Diseases 22(1):368. https:\/\/doi.org\/10.1186\/s12879-022-07258-w","DOI":"10.1186\/s12879-022-07258-w"},{"key":"4418_CR16","doi-asserted-by":"publisher","first-page":"951714","DOI":"10.3389\/fmed.2022.951714","volume":"9","author":"G Song","year":"2022","unstructured":"Song G, Cheng MQ, Li R, Zhang CQ, Sun P (2022) Drug-induced hypersensitivity syndrome with high procalcitonin levels due to piperacillin\/tazobactam and meropenem: a case report. Front Med 9:951714. https:\/\/doi.org\/10.3389\/fmed.2022.951714","journal-title":"Front Med"},{"issue":"4","key":"4418_CR17","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1128\/aac.44.4.943-949.2000","volume":"44","author":"ML van Ogtrop","year":"2000","unstructured":"van Ogtrop ML, Andes D, Stamstad TJ, Conklin B, Weiss WJ, Craig WA et al (2000) In vivo pharmacodynamic activities of two glycylcyclines (GAR-936 and WAY 152,288) against various gram-positive and gram-negative bacteria. Antimicrobial Agents Chemother 44(4):943\u20139. https:\/\/doi.org\/10.1128\/aac.44.4.943-949.2000","journal-title":"Antimicrobial Agents Chemother"},{"issue":"1","key":"4418_CR18","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s13054-018-2125-7","volume":"22","author":"Y Wirz","year":"2018","unstructured":"Wirz Y, Meier MA, Bouadma L, Luyt CE, Wolff M, Chastre J et al (2018) Effect of procalcitonin-guided antibiotic treatment on clinical outcomes in intensive care unit patients with infection and sepsis patients: a patient-level meta-analysis of randomized trials. Critical Care (London, England) 22(1):191. https:\/\/doi.org\/10.1186\/s13054-018-2125-7","journal-title":"Critical Care (London, England)"},{"key":"4418_CR19","doi-asserted-by":"publisher","first-page":"1395260","DOI":"10.3389\/fcimb.2024.1395260","volume":"14","author":"S Zhang","year":"2024","unstructured":"Zhang S, Di L, Qi Y, Qian X, Wang S (2024) Treatment of infections caused by carbapenem-resistant Acinetobacter baumannii. Front Cell Infect Microbiol 14:1395260. https:\/\/doi.org\/10.3389\/fcimb.2024.1395260","journal-title":"Front Cell Infect Microbiol"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04418-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-04418-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04418-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T22:08:37Z","timestamp":1771538917000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-04418-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,6]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["4418"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-04418-y","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,6]]},"assertion":[{"value":"10 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}